Similar Papers

Paper Title
Journal
Date
Author
IgA Nephropathy
Jonathan Barratt ... John Feehally
Journal of the American Society of Nephrology | VOL. 16
Jonathan Barratt, et. al.Jonathan Barratt ... John Feehally
01 Jun 2005
Serum chemokine ligand 5 (CCL5/RANTES) level might be utilized as a predictive marker of tumor behavior and disease prognosis in patients with gastric adenocarcinoma.
Ali Reza Sima ... Hamid Reza Raziee
Journal of Gastrointestinal Cancer | VOL. 45
Ali Reza Sima, et. al.Ali Reza Sima ... Hamid Reza Raziee
10 Oct 2014
Association between plasma factor VIII level and clinical indicators and prognosis in patients with IgA nephropathy
...
-
, et. al. ...
15 Apr 2020
Clinical features, pathological characteristics, and prognosis of patients with IgA nephropathy complicated with nephrotic syndrome
Li Tan ... Qiong Wen
Scientific Reports | VOL. 15
Li Tan, et. al.Li Tan ... Qiong Wen
13 Jan 2025
View more papers

More From: Nephrology Dialysis Transplantation

Paper Title
Journal
Date
Author
Celebrating the life and scientific contributions of Barry Brenner in nephrology
Giuseppe Remuzzi
Nephrology Dialysis Transplantation | VOL. -
Giuseppe RemuzziGiuseppe Remuzzi
20 Sep 2024
Canagliflozin and iron metabolism in the CREDENCE trial
Akihiko Koshino ... Michael K Hansen
Nephrology Dialysis Transplantation | VOL. -
Akihiko Koshino, et. al.Akihiko Koshino ... Michael K Hansen
20 Sep 2024
SELECT: a 10% reduction in body weight with GLP-1 receptor agonists improves kidney outcomes in overweight and obese patients without diabetes
Marieta Theodorakopoulou ... Marius Miglinas
Nephrology Dialysis Transplantation | VOL. -
Marieta Theodorakopoulou, et. al.Marieta Theodorakopoulou ... Marius Miglinas
20 Sep 2024
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease in Children and Adults: a commentary from the European Renal Best Practice (ERBP)
Fotini Iatridi ... Juan Jesus Carrero
Nephrology Dialysis Transplantation | VOL. -
Fotini Iatridi, et. al.Fotini Iatridi ... Juan Jesus Carrero
19 Sep 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.